Healthcare

By

Tim Hesselsweet

 | Nov 23, 2016 | 4:00 PM EST
Technical support and statistical evidence suggest the stock will rebound.
By

Bruce Kamich

 | Nov 23, 2016 | 10:49 AM EST
It will likely take several months of base building before LLY looks better on the charts.
By

Real Money

 | Nov 22, 2016 | 1:49 PM EST
Interpreting "K-M curves" correctly is an important tool for biotech investors.
By

Bret Jensen

 | Nov 22, 2016 | 11:00 AM EST
Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.
By

Tim Hesselsweet

 | Nov 21, 2016 | 12:00 PM EST
Try this put strategy in XLV into the holiday.
By

Paul Price

 | Nov 21, 2016 | 7:00 AM EST
I bought the stock too early, but I am adding more.
RMPIA
By

Bret Jensen

 | Nov 18, 2016 | 10:00 AM EST
With the election resolved, biotech could be ripe for consolidation.
By

Bruce Kamich

 | Nov 17, 2016 | 1:37 PM EST
Prices have marched their way all the way back up to the bottom end of key resistance.
RMPIA
By

Bruce Kamich

 | Nov 17, 2016 | 1:03 PM EST
It looks like CELG could retest the highs around $140.
By

Bruce Kamich

 | Nov 17, 2016 | 10:45 AM EST
But it now or buy it when it's higher.
The great Skip Raschke joins me after the close to talk options, trading and other stuff h...
Big day for TWTR.  The stock is up over 6% with the help of a nice bump in volume.&nb...
Shares of Weyerhaeuser (WY) are breaking above five month horizontal resistance and makin...
This stock is having a strong day with great volume, good flow lately (Feb 140 strikes) an...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.